{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP02958",
    "Peptide Name": "Brevinin-2Ta (B-2Ta; natural AMPs; frog, amphibians, animals; UCSS1a; 1S=S; XXU)",
    "Source": "Pelophylaxkl.esculentus, Europe",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "GILDTLKNLAKTAGKGILKSLVNTASCKLSGQC",
    "Sequence Length": 33,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-",
      "Antifungal",
      "candidacidal",
      "Anti-inflammatory",
      "Wound healing"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Unknown",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 4,
    "Boman Index": 0.54,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "42%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that the sequence of the peptide shows 84.8% similarity toBrevinin-2EB.Activity: Broadly active against S. aureus (MIC 20 uM), E. coli (MIC 10 uM) and C. albicans (MIC 20 uM).Animal model:Rats: B-2Ta effectively restrained the K. pneumoniae infection at a dose of 10 times MIC during the 14 days of the wound healing process.Structure: Predicted to be helical.",
    "Author": "Liu S, Long Q, Xu Y, Wang J, Xu Z, Wang L, Zhou M, Wu Y, Chen T, Shaw C.2017",
    "Reference": "Oncotarget. 2017 Nov 30;8(67):111369-111385. doi: 10.18632/oncotarget.22797.PubMed",
    "Title": "Assessment of antimicrobial and wound healing effects of Brevinin-2Ta against the bacterium Klebsiella pneumoniae in dermally-wounded rats"
  },
  "3D Structure": []
}